PERİ-İMPLANT HASTALIKLARIN TANI VE TEDAVİSİ

Dental implant uygulamaları; diş çürüğü, periodontal hastalık ve travmaya bağlı doğal diş kaybı sonucu ortaya çıkan tam veya kısmi dişsizliklerin tedavisinde büyük bir ilerleme sağlamıştır. Ancak implant oluşmaktadır. Elde edilen veriler uzun dönem implant başarısızlığında bakteriyel enfeksiyonların önemli rol oynadığını periodontitis hikayesi, diabet, genetik özellikler, kötü oral hijyen, sigara kullanımı, alkol tüketimi, keratinize dokunun yetersizliği gibi hasta ile ilişkili faktörler ile seçilen implant sistemi ve tipi, implantın yüzey özellikleri, implanta ve çevre dokulara gelen kuvvetler, implant durumların peri-implant hastalık için risk faktörü olduğu tespit edilmiştir. Bu risk faktörleri; klinik olarak peri-implant enflamasyondan, yıkımla karakterize olan peri-implantitise ve implant kayıplarıyla sonuçlanan durumların oluşmasına neden olmaktadır. Peri-implant hastalıkların teşhisi hastalığın doğru tedavisi için önemlidir. engelleyici destekleyici tedavi (KEDT) olarak tanımlanan bir protokol dahilinde tedavi edilir. Her ne kadar peri-implant hastalıklar ve bu hastalıklara bağlı implant kayıpları görülüyor olsa da, implant tedavisinin, öngörülebilir ve yüksek başarıya sahip bir tedavi seçeneği olduğu, bununla birlikte peri-implant hastalıkların unutulmamalıdır

Diagnosis and Treatment of Peri-Implant Disease

Treatment of total or partial edentulous subjects, caused by dental caries, periodontal disease and tooth loss associated with trauma, has greatly improved dental implants. However, some biological complications have occurred in implant treatment. Obtained data show that bacterial infections have an important role in long term implant failure. In some studies chosen implant system and type, implant surface characteristics, increased forces applied to implant encountered during implant placement and patientrelated factors such as history of periodontitis, diabet, genetic traits, poor oral hygiene, smoking, alcohol consumption and lack of keratinized tissue are shown as risk factors for peri-implant diseases. Clinically, these risk factors cause peri-implant mucositis, periimplantitis and even loss of implant. Diagnosis of periimplant disease is important for right treatment. Periimplant diseases are treated by a protocol described as cumulative interceptive supportive therapy (CIST). Although peri-implant diseases and implant losses are experienced, it should be noted that implant treatment is an alternative that is predictable and highly successful and also peri-implant diseases can be treated

___

  • Zitzmann NU, Berglundh T. Definition and prevalence of peri-implant diseases. J Clin Periodontol. 2008 Sep;35(8 Suppl):286-91.
  • Lindhe J, Wennström JL, Berglundh T. The mucosa at teeth and implants. In: Lindhe J, Lang Periodontology and Implant Dentistry, 5th. Ed., Blackwell Publishing, Munksgaard 2008; pp 69 -85. T.(eds), Clinical
  • Berglundh T, Lindhe J, Ericsson I, et al. The soft tissue barrier at implants and teeth. Clin Oral Implants Res. 1991 Apr-Jun;2(2):81-90.
  • Berglundh T, Lindhe J, Marinello C, et al. Soft tissue reaction to de novo plaque formation on implants and teeth: An experimental study in the dog. Clin Oral Implants Res. 1992 Mar;3 (1):1-8.
  • Hultin M, Gustafsson A, Hallstrom H, et al. Microbiological findings and host response in patients with peri-implantitis. Clin Oral Implants Res. 2002 Aug;13(4):349-58.
  • Socransky SS & Haffajee AD. Periodontal microbial 2005;38:135-87. Periodontol 2000.
  • Apse P, Ellen RP, Overall CM, et al. Microbiota and crevicular fluid collagenase activity in the osseointegrated dental implant sulcus: a comparison of sites in edentulous and partially edentulous patients. J Periodontal Res. 1989 Mar;24(2):96-105.
  • Papaioannou W, Quirynen M, Nys M, et al. The effect of periodontal parameters on the subgingival microbiota around implants. Clin Oral Implants Res. 1995 Dec;6(4):197-204.
  • Mombelli A, van Oosten MA, Schurch E Jr, et al. The microbiota associated with successful or failing osseointegrated titanium implants. Oral Microbiol Immunol. 1987 Dec;2(4):145- 51.
  • Lindhe J, Meyle J. Peri-implant diseases: Consensus Report of the Sixth European Workshop on Periodontology. J Clin Periodontol. 2008 Sep;35(8 Suppl):282-5.
  • Paknejad M, Emtiaz S, Khoobyari MM, et al. Analysis of aspartate aminotransferase and alkaline phosphatase in crevicular fluid from implants with and without peri-implantitis. Implant Dent. 2006 Mar;15(1):62-9.
  • Kullman L, Al-Asfour A, Zetterqvist L, et al. Comparison of radiographic bone height assessments in panoramic and intraoral radiographs of implant patients. Int J Oral Maxillofac Implants. 2007 Jan-Feb;22(1):96- 100.
  • Albouy J-P, Abrahamsson I, Persson LG, et al. Spontaneous progression of ligatured induced periimplantitis at implants with different surface characteristics: An experimental study in dogs histological observations. Clin Oral Implants Res. 2009 Apr;20(4):366-71.
  • Berglundh T, Lindhe J, Lang NP. Peri-implant Mucositis and Peri-implantitis. In: Lindhe J, Lang Periodontology and Implant Dentistry, 5th. Ed., Blackwell Publishing, Munksgaard 2008; pp529-538. T.(eds), Clinical
  • Mombelli A & Lang NP. The diagnosis and treatment of periimplantitis, Periodontol 2000. 1998 Jun;17:63-76.
  • Claffey N, Clarke E, Polyzois I, et al. Surgical treatment Periodontol. 2008 Sep;35(8 Suppl):316-32 J Clin implant surface modifications
  • Berglundh T, Krok L, Liljenberg B, et al. The use of metronidazole and amoxicillin in the treatment of advanced periodontal disease, A prospective, controlled clinical trial. J Clin Periodontol. 1998 May;25(5):354-62.
  • Lang NP, Berglundh T, Heitz-Mayfi eld LJ, et al. Consensus statements and recommended clinical procedures regarding implant survival and complications. Int J Oral Maxillofac Implants. 2004;19 Suppl:150-4.
  • Mombelli A & Lang NP. Anti-microbial treatment of peri-implant infections. Clin Oral Implants Res. 1992 Dec;3(4):162-8.
  • Mombelli A, Feloutzis A, Brägger U. et al. Treatment of peri-implantitis by local delivery of tetracycline: Clinical, microbiological and radiological results. Clin Oral Implants Res. 2001 Aug;12(4):287-94.
  • Wetzel AC, Vlassis J, Caffesse RJ, et al. Attempts following experimental peri-implantitis in dogs. Clin Oral Implants Res. 1999 Apr;10 (2):111-9. re-osseointegration
Sağlık Bilimleri Dergisi-Cover
  • ISSN: 1018-3655
  • Yayın Aralığı: Yılda 3 Sayı
  • Başlangıç: 1993
  • Yayıncı: Prof.Dr. Aykut ÖZDARENDELİ
Sayıdaki Diğer Makaleler

DİAZİNON’UN SIÇAN TESTİSİ ÜZERİNE ETKİLERİNİN HİSTOKİMYASAL OLARAK İNCELENMESİ

Ayşegül Burçin YILDIRIM, Saim ÖZDAMAR

PERİ-İMPLANT HASTALIKLARIN TANI VE TEDAVİSİ

M.Vehbi BAL, Feridun DİŞÇİOĞLU

Geriatrik Köpeklerde Prostat Hastalıklarının Klinik, Radyolojik, Ultrasonorafik ve Laboratuar Muayeneleri ile Araştırılması

Murat KİBAR, Kamuran OLTU, Recep KALIN, Gültekin ATALAN

GEN HARİTALAMA STRATEJİLERİ

Seda ÖRENAY BOYACIOĞLU, Munis DÜNDAR

DENTAL PROTEZLERDE KULLANILAN MIKNATISLARIN OLUŞTURDUĞU STATİK MANYETİK ALANIN İNSAN GİNGİVAL DOKU FİBROBLASTLARININ MİTOTİK AKTİVİTELERİNE OLAN ETKİLERİNİN İN VİTRO İNCELENMESİ

Filiz YAĞCI, Bülent KESİM, Hilal AKALIN, Munis DÜNDAR, Halil İbrahim KILINÇ

2012 YILI MEZUNLARI TEZ ÖZETLERİ (I)

Pridoksin Desteği %3 veya %6 Mısır Yağı İçeren Yemle Beslenen Bıldırcınlarda Canlı Performansı ve Glikoz Hariç Kan Parametrelerini Etkilememiştir

Osman KÜÇÜK

Supplemental pyridoxine had no influence on the live performance and, blood parameters, except glucose, in quails fed 3 or 6% corn oil

Osman KÜÇÜK

GÖMÜLÜ MAKSİLLER KANİN DİŞLERİN ÇEKİMİNİ TAKİBEN İMMEDİAT İMPLANT YERLEŞTİRİLMESİ: 2 VAKA NEDENİYLE

Osman A.ETÖZ, Emrah SOYLU, Erdem KILIÇ, Alper ALKAN

IN VITRO ACTIVITY OF QUINUPRISTIN-DALFOPRISTIN, METHICILLIN AND VANCOMYCIN AGAINST STAPHYLOCOCCUS STRAINS ISOLATED FROM CLINICAL SAMPLES

Erkan YULA, Turkan TOKA ÖZER, Ozcan DEVECİ, Alicem TEKİN, Keramettin YANIK, Suleyman DURMAZ